This review highlights current research on the neuroimmune mechanisms underlying goblet cell metaplasia and degranulation, focusing on allergic rhinitis, so as to guide clinical treatment strategies .

Another study analyzed treatment outcomes in 48 patients with excessive belching. After 10 sessions of speech therapy, 83% reported less burping. Breathing techniques can reduce burping and ...

"Even though we were upset and a little upset, we (told) the doctor immediately, 'We want to get involved in research,'" Karen Walsh said.Joe Walsh is now testing a new treatment using a nasal ...

The following is a summary of “Unveiling the Prevalence and Impact of Silent Rhinovirus Infection in Chronic Rhinosinusitis with Nasal Polyps,” published in the January 2025 issue of Annals of Allergy ...

"We're So Doomed": People Are Sharing Their Unfiltered Reactions To RFK Jr. Being Confirmed As Health Secretary, And It's Bleak Several Different Brands Of Canned Tuna Have Been Recalled Due Their ...

Bilateral versus unilateral cases of chronic rhinosinusitis with nasal polyps have notable clinical and laboratory ...

While lifestyle modifications may help prevent this weight loss side effect, a doctor may recommend surgery to treat excess, sagging skin. Keep reading for information about “Ozempic butt” and ...

Post-nasal drip occurs when excess mucus accumulates in the back of the throat or nose, primarily due to allergies, ...

9NEWS Medical Expert Dr. Payal Kohli weighs in on a new nasal spray being used to treat depression. The 2025 Oscar Nominations Are Finally Here 14 Outdated Home Trends That Are Lowering Your ...

approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a standalone treatment, is "the first and only ...

(WXYZ) — In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression. It's called Spravato, made by Johnson ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...